Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

A group has developed therapies that show promise for treating cancer and various other conditions.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Etoposide makes radiation therapy more effective against tumors without major side effects.

Exosomes show promise for targeted treatment of HER2-positive breast cancer.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

The treatment is safe and shows promise for metastatic breast cancer.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Immunoadsorption successfully treated a man's resistant polymyositis.

Chemotherapy may help with survival in children with medulloblastoma, but more research is needed.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

Rituximab may cause skin issues, but baricitinib can help improve them.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Stereotactic body radiation therapy and radiosurgery are advanced, precise treatments that target tumors while protecting healthy tissue.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Clofazimine effectively treated ashy dermatosis in a patient.